# Effect of Regulated Add -on Sodium Chloride Intake on Stabilization of Serum Lithium Concentration in Bipolar Disorder

> **NCT04222816** · PHASE4 · COMPLETED · sponsor: **All India Institute of Medical Sciences, Bhubaneswar** · enrollment: 60 (actual)

## Conditions studied

- Bipolar Affective Disorder

## Interventions

- **DRUG:** Lithium Carbonate
- **DRUG:** Sodium chloride

## Key facts

- **NCT ID:** NCT04222816
- **Lead sponsor:** All India Institute of Medical Sciences, Bhubaneswar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-16
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-01-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04222816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04222816, "Effect of Regulated Add -on Sodium Chloride Intake on Stabilization of Serum Lithium Concentration in Bipolar Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04222816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*